Kastelein Johannes Jacob Pieter's Form 4 filing
NewAmsterdam Pharma Co N.V. (NAMS) · filed Mar 27, 2024
- Accession no.
- 0000950170-24-037241
- Filed
- Mar 27, 2024
- Trade date
- Mar 26, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.10M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kastelein Johannes Jacob PieterCIK 0002000389 | Director, Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2024 | Ordinary Shares | MOption exerciseAcquired | +201,673 | – | – | 201,673 | Indirect | |
| Mar 26, 2024 | Ordinary Shares | FTax withholdingDisposed | −11,197 | $22.72 | −$254,395.84 | 190,476 | Indirect | |
| Mar 26, 2024 | Ordinary Shares | SSaleDisposed | −190,476 | $21.50 | −$4,095,234 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2024 | Ordinary Shares | MOption exerciseDisposed | −201,673 | $0.00 | $0 | 970,229 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.